SCHEMBL8775692

SCHEMBL8775692

COc1cccc(Cl)c1-c1cccc(-c2ncc3ccccc3n2)n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 6/20 0.47
KMT2A Q03164 4/20 0.47
CYP1A2 P05177 3/20 0.47
MEN1 O00255 3/20 0.47
CYP2C9 P11712 2/20 0.47
CYP2C19 P33261 2/20 0.47
NPSR1 Q6W5P4 1/20 0.47
LMNA P02545 4/20 0.47
HSP90AA1 P07900 3/20 0.45
HSP90AB1 P08238 2/20 0.45
MAPT P10636 5/20 0.42
PPP1CA P62136 5/20 0.42
ALDH1A1 P00352 2/20 0.42
CYP3A4 P08684 1/20 0.39
ELANE P08246 1/20 0.39
HTR7 P34969 1/20 0.38
NQO2 P16083 1/20 0.38
L3MBTL1 Q9Y468 3/20 0.38
POLB P06746 2/20 0.38
NPC1 O15118 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8776232 0.91 HTR7 (0.45) SMN1; SMN2KMT2ACYP1A2MEN1CYP2C9
SCHEMBL8775767 0.85 MAP4K1 (0.47) SMN1; SMN2KMT2AMEN1PPP1CAALDH1A1
SCHEMBL8776528 0.85 MEN1 (0.41) SMN1; SMN2KMT2ACYP1A2MEN1CYP2C9
SCHEMBL8775247 0.82 ALDH1A1 (0.46) SMN1; SMN2KMT2ACYP1A2MEN1CYP2C19
SCHEMBL8775976 0.81 SMN1; SMN2 (0.49) SMN1; SMN2KMT2ACYP1A2MEN1CYP2C9
SCHEMBL8775356 0.79 SMN1; SMN2 (0.47) SMN1; SMN2KMT2ACYP1A2MEN1CYP2C9
SCHEMBL8775805 0.78 ALDH1A1 (0.44) SMN1; SMN2KMT2ACYP1A2MEN1CYP2C9
SCHEMBL8776077 0.78 MAOA (0.44) SMN1; SMN2KMT2ACYP1A2MEN1CYP2C9
SCHEMBL8777306 0.78 MEN1 (0.39) SMN1; SMN2KMT2ACYP1A2MEN1CYP2C9
SCHEMBL8775144 0.77 CYP1A2 (0.44) SMN1; SMN2KMT2ACYP1A2MEN1CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012069652-A2 FUNGICIDE MIXTURES SYNGENTA PARTICIPATIONS AG (CH) 2012-05-31 WO disclosed
US-20120129875-A1 SUBSTITUTED QUINAZOLINES AS FUNGICIDES SYNGENTA CROP PROTECTION, LLC (US) 2012-05-24 US disclosed
WO-2010136475-A1 SUBSTITUTED QUINAZOLINES AS FUNGICIDES SYNGENTA PARTICIPATIONS AG (CH) 2010-12-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120129875-A1 SUBSTITUTED QUINAZOLINES AS FUNGICIDES NAT1, NQO2, NOX1 SMN1; SMN2 3646/4885KMT2A 2145/4885CYP1A2 18/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.